PT - JOURNAL ARTICLE AU - Alistair Thorpe AU - Angela Fagerlin AU - Frank A. Drews AU - Holly Shoemaker AU - Federica S. Brecha AU - Laura D. Scherer TI - Predictors of COVID-19 vaccine uptake: An online longitudinal study of US Veterans and non-Veterans AID - 10.1101/2022.04.19.22273818 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.19.22273818 4099 - http://medrxiv.org/content/early/2022/05/23/2022.04.19.22273818.short 4100 - http://medrxiv.org/content/early/2022/05/23/2022.04.19.22273818.full AB - Background To effectively promote vaccine uptake, it is important to understand which people are most and least inclined to be vaccinated and why.Purpose To identify predictors of COVID-19 vaccine uptake and reasons for non-vaccination.Design A longitudinal English-language survey study.Setting Online in December-2020, January-2021, and March-2021. Participants. 930 US respondents (63% Veterans).Measurements Surveys included questions about respondents’ behaviors, well-being, healthcare experiences, and attitudes regarding the pandemic.Results The proportion of respondents who received ≥1-dose of a COVID-19 vaccine increased from 18% in January to 67% in March. Older age predicted vaccine uptake in January (OR=2.02[95%CI=1.14–3.78], p<.001) and March (10.92[6.76–18.05], p<.001). In January, additional predictors of vaccine uptake were higher numeracy (1.48[1.20–1.86], p<.001), COVID-19 risk perceptions (1.35[1.03–1.78], p=.029), and believing it is important that adults get the COVID-19 vaccine (1.66[1.05–2.66], p=.033). In March, additional predictors of vaccine uptake were believing it is important that adults get the COVID-19 vaccine (1.63[1.15–2.34], p=.006), previous (January) COVID-19 vaccine intentions (1.37[1.10–1.72], p=.006), and belief in science (0.84[0.72–0.99], p=.041). Concerns about side effects and the vaccine development process were the most common reasons for non-vaccination. Unvaccinated respondents with no interest in getting a COVID-19 vaccine were younger (0.27[0.09–0.77], p=.016), held negative views about COVID-19 vaccines for adults (0.15[0.08–0.26], p<.001), had lower trust in healthcare (0.59[0.36–0.95], p=.032), and preferred to watch and wait in clinically ambiguous medical situations (0.66[0.48–0.89], p=.007).Limitations Reliance on the accuracy and consistency of self-reported data.Conclusion These findings offer important insights regarding key predictors of vaccine uptake during the early stages of the COVID-19 vaccine rollout in the US, which can help guide health communications and public outreach. Evidence that attitudes and intentions towards COVID-19 vaccines are important predictors of uptake provides validation for studies which have used these measures and reinforces the need to develop effective strategies for addressing concerns about vaccine safety and development which continue to be at the forefront of vaccine hesitancy.Registration The pre-registration document associated with this manuscript is available at: https://aspredicted.org/MKS_HRZ.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Thorpe was supported by grant No. 51300302 from the American Heart Association Children's Strategically Focused Research Network fellowship awarded to Dr. Fagerlin. Funding for the study was provided by the VA (VA C-19-20-205; for recruitment of Veterans) to Drs. Fagerlin & Scherer and Dr. Fagerlin's Jon M. Huntsman Presidential Endowed Chair (for recruitment of non-Veterans).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved (deemed exempt) by the IRBs at the University of Utah and the Salt Lake City VA (Veterans Experiences During the COVID-19 Pandemic: IRB_00133198).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and study materials are available from the first author upon request.